Barclays’s FT Vest US Equity Deep Buffer ETF October DOCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$186K Buy
4,294
+3,934
+1,093% +$174K ﹤0.01% 3727
2025
Q4
$15.9K Sell
360
-511
-59% -$22.4K ﹤0.01% 4894
2025
Q3
$37.6K Sell
871
-4,132
-83% -$174K ﹤0.01% 4834
2025
Q2
$205K Buy
5,003
+3,282
+191% +$128K ﹤0.01% 4255
2025
Q1
$66K Sell
1,721
-2,018
-54% -$79.6K ﹤0.01% 4537
2024
Q4
$147K Sell
3,739
-1,393
-27% -$54.8K ﹤0.01% 4454
2024
Q3
$200K Buy
+5,132
New +$198K ﹤0.01% 4284

Other funds holding DOCT

Barclays's DOCT Position: Q1 2026 in Review

Barclays increased its FT Vest US Equity Deep Buffer ETF October (DOCT) stake by 1,093% in Q1 2026, buying an estimated $174K and bringing the position to 4,294 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #3727.

Barclays first reported a position in DOCT in Q3 2024 and has held it in 7 quarters since. The position peaked at $205K in Q2 2025. 111 funds tracked by Wall St. Rank hold DOCT as of Q1 2026.

  • Barclays held 4,294 shares of FT Vest US Equity Deep Buffer ETF October worth $186K as of Q1 2026.
  • Barclays bought 3,934 FT Vest US Equity Deep Buffer ETF October shares in Q1 2026, an estimated $174K.
  • FT Vest US Equity Deep Buffer ETF October made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3727 holding.
  • Barclays first reported a position in FT Vest US Equity Deep Buffer ETF October in Q3 2024 and has held it in 7 quarters since.
  • Barclays's FT Vest US Equity Deep Buffer ETF October position peaked at $205K in Q2 2025.
  • 111 funds tracked by Wall St. Rank held FT Vest US Equity Deep Buffer ETF October as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.